Transplantation, Kidney Clinical Trial
Official title:
Does Contrast-Enhanced Ultrasound Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
This is a pilot study to investigate whether contrast-enhanced ultrasound (CEUS) may help evaluate segmental differences in renal perfusion better than Doppler Ultrasound and thus help direct the biopsy to the most abnormal part of the renal cortex. This should maximize detection and increase the odds of demonstrating the true grade/severity of the histopathological abnormality.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00189735 -
A Study to Evaluate FK778 in Kidney Transplant Patients
|
Phase 2 | |
| Recruiting |
NCT01150487 -
Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients
|
N/A | |
| Completed |
NCT01656343 -
Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
|
||
| Not yet recruiting |
NCT00617474 -
The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group
|
Phase 1 | |
| Terminated |
NCT00365833 -
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
|
N/A | |
| Withdrawn |
NCT01496729 -
Transversus Abdominis Plane (TAP) Block After Kidney Transplantation
|
N/A | |
| Completed |
NCT00861536 -
Comparison of ATG to Thymoglobuline in Renal Transplantation
|
Phase 4 | |
| Completed |
NCT00614081 -
GFR Measurement With Contrast-enhanced Dynamic MRI
|
N/A | |
| Completed |
NCT03977051 -
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
|
||
| Terminated |
NCT00568477 -
Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
|
Phase 2 | |
| Completed |
NCT04874740 -
Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region
|
||
| Available |
NCT01236287 -
Special Access for the Use of Voclosporin for Kidney Transplantation
|